Influenza Vaccine Market, Global Outlook and Forecast 2022-2028
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report contains market size and forecasts of Influenza Vaccine in global, including the following market information:
Global Influenza Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Influenza Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Influenza Vaccine companies in 2021 (%)
The global Influenza Vaccine market was valued at 7819.9 million in 2021 and is projected to reach US$ 11060 million by 2028, at a CAGR of 5.1% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Influenza Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Influenza Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Influenza Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Influenza Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Influenza Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Influenza Vaccine revenues share in global market, 2021 (%)
Key companies Influenza Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Influenza Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Influenza Vaccine in global, including the following market information:
Global Influenza Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Influenza Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Influenza Vaccine companies in 2021 (%)
The global Influenza Vaccine market was valued at 7819.9 million in 2021 and is projected to reach US$ 11060 million by 2028, at a CAGR of 5.1% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Influenza Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Influenza Vaccine Market Segment Percentages, by Type, 2021 (%)
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
Global Influenza Vaccine Market Segment Percentages, by Application, 2021 (%)
- 6 Months to 3 Years
- > 3 Years
Global Influenza Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Influenza Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Influenza Vaccine revenues share in global market, 2021 (%)
Key companies Influenza Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Influenza Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu GDK
- KM Biologics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFLUENZA VACCINE OVERALL MARKET SIZE
2.1 Global Influenza Vaccine Market Size: 2021 VS 2028
2.2 Global Influenza Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Influenza Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Influenza Vaccine Players in Global Market
3.2 Top Global Influenza Vaccine Companies Ranked by Revenue
3.3 Global Influenza Vaccine Revenue by Companies
3.4 Global Influenza Vaccine Sales by Companies
3.5 Global Influenza Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Influenza Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Influenza Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Influenza Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Influenza Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Influenza Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Influenza Vaccine Sales, 2017-2022
4.3.2 By Type - Global Influenza Vaccine Sales, 2023-2028
4.3.3 By Type - Global Influenza Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Influenza Vaccine Market Size, 2021 & 2028
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application - Global Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Influenza Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Influenza Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Influenza Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Influenza Vaccine Sales, 2017-2022
5.3.2 By Application - Global Influenza Vaccine Sales, 2023-2028
5.3.3 By Application - Global Influenza Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Influenza Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Influenza Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Influenza Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Influenza Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Influenza Vaccine Sales, 2017-2022
6.3.2 By Region - Global Influenza Vaccine Sales, 2023-2028
6.3.3 By Region - Global Influenza Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Influenza Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Influenza Vaccine Sales, 2017-2028
6.4.3 US Influenza Vaccine Market Size, 2017-2028
6.4.4 Canada Influenza Vaccine Market Size, 2017-2028
6.4.5 Mexico Influenza Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Influenza Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Influenza Vaccine Sales, 2017-2028
6.5.3 Germany Influenza Vaccine Market Size, 2017-2028
6.5.4 France Influenza Vaccine Market Size, 2017-2028
6.5.5 U.K. Influenza Vaccine Market Size, 2017-2028
6.5.6 Italy Influenza Vaccine Market Size, 2017-2028
6.5.7 Russia Influenza Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Influenza Vaccine Market Size, 2017-2028
6.5.9 Benelux Influenza Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Influenza Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Influenza Vaccine Sales, 2017-2028
6.6.3 China Influenza Vaccine Market Size, 2017-2028
6.6.4 Japan Influenza Vaccine Market Size, 2017-2028
6.6.5 South Korea Influenza Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Influenza Vaccine Market Size, 2017-2028
6.6.7 India Influenza Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Influenza Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Influenza Vaccine Sales, 2017-2028
6.7.3 Brazil Influenza Vaccine Market Size, 2017-2028
6.7.4 Argentina Influenza Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Influenza Vaccine Sales, 2017-2028
6.8.3 Turkey Influenza Vaccine Market Size, 2017-2028
6.8.4 Israel Influenza Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Influenza Vaccine Market Size, 2017-2028
6.8.6 UAE Influenza Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Influenza Vaccine Major Product Offerings
7.1.4 Sanofi Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Influenza Vaccine Major Product Offerings
7.2.4 CSL Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CSL Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Influenza Vaccine Major Product Offerings
7.3.4 GSK Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Viatris
7.4.1 Viatris Corporate Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Influenza Vaccine Major Product Offerings
7.4.4 Viatris Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Viatris Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Influenza Vaccine Major Product Offerings
7.5.4 AstraZeneca Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Hualan Bio
7.6.1 Hualan Bio Corporate Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Influenza Vaccine Major Product Offerings
7.6.4 Hualan Bio Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Hualan Bio Key News
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Corporate Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Influenza Vaccine Major Product Offerings
7.7.4 Changchun Institute of Biological Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Changchun Institute of Biological Key News
7.8 Sinovac
7.8.1 Sinovac Corporate Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Influenza Vaccine Major Product Offerings
7.8.4 Sinovac Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Sinovac Key News
7.9 BCHT
7.9.1 BCHT Corporate Summary
7.9.2 BCHT Business Overview
7.9.3 BCHT Influenza Vaccine Major Product Offerings
7.9.4 BCHT Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 BCHT Key News
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Corporate Summary
7.10.2 Jiangsu GDK Business Overview
7.10.3 Jiangsu GDK Influenza Vaccine Major Product Offerings
7.10.4 Jiangsu GDK Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Jiangsu GDK Key News
7.11 KM Biologics
7.11.1 KM Biologics Corporate Summary
7.11.2 KM Biologics Influenza Vaccine Business Overview
7.11.3 KM Biologics Influenza Vaccine Major Product Offerings
7.11.4 KM Biologics Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 KM Biologics Key News
8 GLOBAL INFLUENZA VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Influenza Vaccine Production Capacity, 2017-2028
8.2 Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INFLUENZA VACCINE SUPPLY CHAIN ANALYSIS
10.1 Influenza Vaccine Industry Value Chain
10.2 Influenza Vaccine Upstream Market
10.3 Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFLUENZA VACCINE OVERALL MARKET SIZE
2.1 Global Influenza Vaccine Market Size: 2021 VS 2028
2.2 Global Influenza Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Influenza Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Influenza Vaccine Players in Global Market
3.2 Top Global Influenza Vaccine Companies Ranked by Revenue
3.3 Global Influenza Vaccine Revenue by Companies
3.4 Global Influenza Vaccine Sales by Companies
3.5 Global Influenza Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Influenza Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Influenza Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Influenza Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Influenza Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Influenza Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Influenza Vaccine Sales, 2017-2022
4.3.2 By Type - Global Influenza Vaccine Sales, 2023-2028
4.3.3 By Type - Global Influenza Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Influenza Vaccine Market Size, 2021 & 2028
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application - Global Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Influenza Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Influenza Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Influenza Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Influenza Vaccine Sales, 2017-2022
5.3.2 By Application - Global Influenza Vaccine Sales, 2023-2028
5.3.3 By Application - Global Influenza Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Influenza Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Influenza Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Influenza Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Influenza Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Influenza Vaccine Sales, 2017-2022
6.3.2 By Region - Global Influenza Vaccine Sales, 2023-2028
6.3.3 By Region - Global Influenza Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Influenza Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Influenza Vaccine Sales, 2017-2028
6.4.3 US Influenza Vaccine Market Size, 2017-2028
6.4.4 Canada Influenza Vaccine Market Size, 2017-2028
6.4.5 Mexico Influenza Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Influenza Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Influenza Vaccine Sales, 2017-2028
6.5.3 Germany Influenza Vaccine Market Size, 2017-2028
6.5.4 France Influenza Vaccine Market Size, 2017-2028
6.5.5 U.K. Influenza Vaccine Market Size, 2017-2028
6.5.6 Italy Influenza Vaccine Market Size, 2017-2028
6.5.7 Russia Influenza Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Influenza Vaccine Market Size, 2017-2028
6.5.9 Benelux Influenza Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Influenza Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Influenza Vaccine Sales, 2017-2028
6.6.3 China Influenza Vaccine Market Size, 2017-2028
6.6.4 Japan Influenza Vaccine Market Size, 2017-2028
6.6.5 South Korea Influenza Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Influenza Vaccine Market Size, 2017-2028
6.6.7 India Influenza Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Influenza Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Influenza Vaccine Sales, 2017-2028
6.7.3 Brazil Influenza Vaccine Market Size, 2017-2028
6.7.4 Argentina Influenza Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Influenza Vaccine Sales, 2017-2028
6.8.3 Turkey Influenza Vaccine Market Size, 2017-2028
6.8.4 Israel Influenza Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Influenza Vaccine Market Size, 2017-2028
6.8.6 UAE Influenza Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Influenza Vaccine Major Product Offerings
7.1.4 Sanofi Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Influenza Vaccine Major Product Offerings
7.2.4 CSL Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CSL Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Influenza Vaccine Major Product Offerings
7.3.4 GSK Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Viatris
7.4.1 Viatris Corporate Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Influenza Vaccine Major Product Offerings
7.4.4 Viatris Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Viatris Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Influenza Vaccine Major Product Offerings
7.5.4 AstraZeneca Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Hualan Bio
7.6.1 Hualan Bio Corporate Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Influenza Vaccine Major Product Offerings
7.6.4 Hualan Bio Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Hualan Bio Key News
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Corporate Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Influenza Vaccine Major Product Offerings
7.7.4 Changchun Institute of Biological Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Changchun Institute of Biological Key News
7.8 Sinovac
7.8.1 Sinovac Corporate Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Influenza Vaccine Major Product Offerings
7.8.4 Sinovac Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Sinovac Key News
7.9 BCHT
7.9.1 BCHT Corporate Summary
7.9.2 BCHT Business Overview
7.9.3 BCHT Influenza Vaccine Major Product Offerings
7.9.4 BCHT Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 BCHT Key News
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Corporate Summary
7.10.2 Jiangsu GDK Business Overview
7.10.3 Jiangsu GDK Influenza Vaccine Major Product Offerings
7.10.4 Jiangsu GDK Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Jiangsu GDK Key News
7.11 KM Biologics
7.11.1 KM Biologics Corporate Summary
7.11.2 KM Biologics Influenza Vaccine Business Overview
7.11.3 KM Biologics Influenza Vaccine Major Product Offerings
7.11.4 KM Biologics Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 KM Biologics Key News
8 GLOBAL INFLUENZA VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Influenza Vaccine Production Capacity, 2017-2028
8.2 Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INFLUENZA VACCINE SUPPLY CHAIN ANALYSIS
10.1 Influenza Vaccine Industry Value Chain
10.2 Influenza Vaccine Upstream Market
10.3 Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Influenza Vaccine in Global Market
Table 2. Top Influenza Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Influenza Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Influenza Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Influenza Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Influenza Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Influenza Vaccine Price (2017-2022) & (USD/Doses)
Table 8. Global Manufacturers Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Influenza Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Influenza Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Influenza Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Influenza Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Influenza Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Influenza Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Influenza Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Influenza Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Influenza Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Influenza Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Influenza Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Influenza Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Influenza Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Influenza Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Influenza Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Influenza Vaccine Sales, (M Doses), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Influenza Vaccine Product Offerings
Table 48. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 49. CSL Corporate Summary
Table 50. CSL Influenza Vaccine Product Offerings
Table 51. CSL Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Influenza Vaccine Product Offerings
Table 54. GSK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 55. Viatris Corporate Summary
Table 56. Viatris Influenza Vaccine Product Offerings
Table 57. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Influenza Vaccine Product Offerings
Table 60. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 61. Hualan Bio Corporate Summary
Table 62. Hualan Bio Influenza Vaccine Product Offerings
Table 63. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 64. Changchun Institute of Biological Corporate Summary
Table 65. Changchun Institute of Biological Influenza Vaccine Product Offerings
Table 66. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 67. Sinovac Corporate Summary
Table 68. Sinovac Influenza Vaccine Product Offerings
Table 69. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 70. BCHT Corporate Summary
Table 71. BCHT Influenza Vaccine Product Offerings
Table 72. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 73. Jiangsu GDK Corporate Summary
Table 74. Jiangsu GDK Influenza Vaccine Product Offerings
Table 75. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 76. KM Biologics Corporate Summary
Table 77. KM Biologics Influenza Vaccine Product Offerings
Table 78. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 79. Influenza Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 80. Global Influenza Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Influenza Vaccine Production by Region, 2017-2022 (M Doses)
Table 82. Global Influenza Vaccine Production by Region, 2023-2028 (M Doses)
Table 83. Influenza Vaccine Market Opportunities & Trends in Global Market
Table 84. Influenza Vaccine Market Drivers in Global Market
Table 85. Influenza Vaccine Market Restraints in Global Market
Table 86. Influenza Vaccine Raw Materials
Table 87. Influenza Vaccine Raw Materials Suppliers in Global Market
Table 88. Typical Influenza Vaccine Downstream
Table 89. Influenza Vaccine Downstream Clients in Global Market
Table 90. Influenza Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Influenza Vaccine in Global Market
Table 2. Top Influenza Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Influenza Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Influenza Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Influenza Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Influenza Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Influenza Vaccine Price (2017-2022) & (USD/Doses)
Table 8. Global Manufacturers Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Influenza Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Influenza Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Influenza Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Influenza Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Influenza Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Influenza Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Influenza Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Influenza Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Influenza Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Influenza Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Influenza Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Influenza Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Influenza Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Influenza Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Influenza Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Influenza Vaccine Sales, (M Doses), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Influenza Vaccine Product Offerings
Table 48. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 49. CSL Corporate Summary
Table 50. CSL Influenza Vaccine Product Offerings
Table 51. CSL Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Influenza Vaccine Product Offerings
Table 54. GSK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 55. Viatris Corporate Summary
Table 56. Viatris Influenza Vaccine Product Offerings
Table 57. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Influenza Vaccine Product Offerings
Table 60. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 61. Hualan Bio Corporate Summary
Table 62. Hualan Bio Influenza Vaccine Product Offerings
Table 63. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 64. Changchun Institute of Biological Corporate Summary
Table 65. Changchun Institute of Biological Influenza Vaccine Product Offerings
Table 66. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 67. Sinovac Corporate Summary
Table 68. Sinovac Influenza Vaccine Product Offerings
Table 69. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 70. BCHT Corporate Summary
Table 71. BCHT Influenza Vaccine Product Offerings
Table 72. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 73. Jiangsu GDK Corporate Summary
Table 74. Jiangsu GDK Influenza Vaccine Product Offerings
Table 75. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 76. KM Biologics Corporate Summary
Table 77. KM Biologics Influenza Vaccine Product Offerings
Table 78. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 79. Influenza Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 80. Global Influenza Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Influenza Vaccine Production by Region, 2017-2022 (M Doses)
Table 82. Global Influenza Vaccine Production by Region, 2023-2028 (M Doses)
Table 83. Influenza Vaccine Market Opportunities & Trends in Global Market
Table 84. Influenza Vaccine Market Drivers in Global Market
Table 85. Influenza Vaccine Market Restraints in Global Market
Table 86. Influenza Vaccine Raw Materials
Table 87. Influenza Vaccine Raw Materials Suppliers in Global Market
Table 88. Typical Influenza Vaccine Downstream
Table 89. Influenza Vaccine Downstream Clients in Global Market
Table 90. Influenza Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Influenza Vaccine Segment by Type
Figure 2. Influenza Vaccine Segment by Application
Figure 3. Global Influenza Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Influenza Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Influenza Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Influenza Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Vaccine Revenue in 2021
Figure 9. By Type - Global Influenza Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Influenza Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Influenza Vaccine Price (USD/Doses), 2017-2028
Figure 12. By Application - Global Influenza Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Influenza Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Influenza Vaccine Price (USD/Doses), 2017-2028
Figure 15. By Region - Global Influenza Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Influenza Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Influenza Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Influenza Vaccine Sales Market Share, 2017-2028
Figure 19. US Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Influenza Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Influenza Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Influenza Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Influenza Vaccine Sales Market Share, 2017-2028
Figure 33. China Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Influenza Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Influenza Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Influenza Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Influenza Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Influenza Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Influenza Vaccine by Region, 2021 VS 2028
Figure 50. Influenza Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Influenza Vaccine Segment by Type
Figure 2. Influenza Vaccine Segment by Application
Figure 3. Global Influenza Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Influenza Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Influenza Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Influenza Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Vaccine Revenue in 2021
Figure 9. By Type - Global Influenza Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Influenza Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Influenza Vaccine Price (USD/Doses), 2017-2028
Figure 12. By Application - Global Influenza Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Influenza Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Influenza Vaccine Price (USD/Doses), 2017-2028
Figure 15. By Region - Global Influenza Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Influenza Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Influenza Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Influenza Vaccine Sales Market Share, 2017-2028
Figure 19. US Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Influenza Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Influenza Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Influenza Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Influenza Vaccine Sales Market Share, 2017-2028
Figure 33. China Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Influenza Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Influenza Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Influenza Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Influenza Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Influenza Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Influenza Vaccine by Region, 2021 VS 2028
Figure 50. Influenza Vaccine Industry Value Chain
Figure 51. Marketing Channels
